The Mary Lyon Centre, Medical Research Council Harwell Institute, Harwell Campus, Didcot OX11 0RD, Oxon, UK.
Université de Strasbourg, CNRS, INSERM, IGBMC, PHENOMIN-Institut Clinique de la Souris, Celphedia, Strasbourg 67404, France.
Mol Ther. 2020 Jun 3;28(6):1422-1431. doi: 10.1016/j.ymthe.2020.03.015. Epub 2020 Mar 20.
Genome editing tools have already revolutionized biomedical research and are also expected to have an important impact in the clinic. However, their extensive use in research has revealed much unpredictability, both off and on target, in the outcome of their application. We discuss the challenges associated with this unpredictability, both for research and in the clinic. For the former, an extensive validation of the model is essential. For the latter, potential unpredicted activity does not preclude the use of these tools but requires that molecular evidence to underpin the relevant risk:benefit evaluation is available. Safe and successful clinical application will also depend on the mode of delivery and the cellular context.
基因组编辑工具已经彻底改变了生物医学研究,预计也将对临床产生重要影响。然而,它们在研究中的广泛应用揭示了其应用结果既有预期内的,也有预期外的不可预测性。我们讨论了与这种不可预测性相关的挑战,无论是在研究方面还是在临床方面。对于前者,模型的广泛验证是必不可少的。对于后者,潜在的不可预测的活动并不排除这些工具的使用,但需要有分子证据来支持相关的风险效益评估。安全和成功的临床应用也将取决于给药方式和细胞环境。